MedTrace Logo

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

NCT07136467 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2795

Last updated 2026-02-13

No results posted yet for this study

Summary

This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.

Conditions

Sponsors & Collaborators

Principal Investigators

  • ABBVIE INC. · AbbVie

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-02
Primary Completion
2027-08-31
Completion
2027-08-31

Countries

  • Argentina
  • Canada
  • Colombia
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Italy
  • Japan
  • Latvia
  • Puerto Rico
  • Romania
  • South Korea
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07136467 on ClinicalTrials.gov